Embolic Protection Devices Market Report Scope & Overview:
The embolic protection devices market size was valued at USD 656.60 million in 2024 and is expected to reach USD 1276.14 million by 2032, growing at a CAGR of 8.68% over the forecast period of 2025-2032.
The global Embolic Protection Devices Market is driven by the increasing incidence of cardiovascular diseases, demand for minimally invasive procedures, and growth in government and nongovernment initiatives to promote stroke awareness. Some of the primary embolic protection devices market trends are rising device utilization in the TAVR (transcatheter aortic valve replacement) segment, technological advancement in filters and occlusion systems, growing adoption in carotid stenting, and the trend towards ambulatory centers.
For instance, in March 2025, Boston Scientific reported that its Sentinel cerebral protection device was used in over 200,000 TAVR procedures globally, highlighting rapid adoption in structural heart interventions.
Key Embolic Protection Devices Market Trends
-
Rising prevalence of cardiovascular diseases is driving demand for embolic protection devices worldwide.
-
Minimally invasive interventions including PCI and TAVR are increasing the adoption of EPDs to prevent embolic complications.
-
Technological advancements in filter-based and distal protection devices are improving safety and clinical outcomes.
-
Growing awareness among clinicians and patients about stroke and embolization risks is boosting adoption.
-
Regulatory guidelines and recommendations are encouraging wider use during high-risk cardiovascular procedures.
-
Integration with imaging and navigation systems enables precise deployment and real-time monitoring, creating new business opportunities
Embolic Protection Devices Market Report Highlights
The U.S. embolic protection devices market was valued at USD 156.75 million in 2024 and is expected to reach USD 297.74 million by 2032, growing at a CAGR of 8.37% over 2025-2032. The U.S. is a dominant market for the embolic protection devices due to the high prevalence of cardiovascular diseases, developed healthcare domain, and massive implementation of PCI and TAVR procedures. Positive reimbursement policies, high physician awareness, and burgeoning technology uptake will also support market expansion. On the back of these factors, the U.S. emerges as the largest regional market for embolic protection devices market analysis.
Embolic protection devices market trends are expected to witness significant growth during the forecast period, owing to the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, technological advancements in device design, and growing awareness among clinicians and patients.
Key Embolic Protection Devices Market Segment Analysis
-
By Product, distal filters held the largest share of around 41.38% in 2024, and the distal occlusion systems segment is expected to register the highest growth with a CAGR of 9.27%.
-
By application, the cardiovascular diseases segment dominated the market with approximately 48.83% share in 2024, whereas the neurovascular diseases segment is expected to register the highest growth with a CAGR of 9.04%.
-
By indication, percutaneous coronary intervention accounted for the leading share of nearly 40.88% in 2024, and the transcatheter aortic valve replacement segment is expected to register the highest growth with a CAGR of 9.54%.
-
By end-user, the hospitals segment led the market with about 72.88% share in 2024, while the IT sector segment is forecasted to grow the fastest at a CAGR of 15.51%.
By Type, Distal Filters Lead Market and Distal Occlusion Systems Registers Fastest Growth
In 2024, the distal filters segment held a commanding revenue of around 41.38% in the embolic protection devices market share and is expected to continue its dominance owing to its widespread use in clinical practice in PCI, carotid artery stenting, and TAVR. Key drivers are easy deliverability, established embolic debris capture effectiveness, high physician experience, and positive clinical evidence for reducing stroke. The distal occlusion systems segment is projected to experience the fastest CAGR growth of around 9.27%, driving the growth of this market, including increased embolic protection efficacy, a lower number of procedural complications.
By Application, Cardiovascular Diseases Dominate While Neurovascular Diseases Show Rapid Growth
The embolic protection devices market was dominated by the cardiovascular diseases segment with a revenue share of over 48.83% in 2024. Key market drivers include compelling clinical data, increased physician adoption, positive reimbursement, and continued development in the filter and occlusion device designs that help maintain this product line's dominant global market share. On the other hand, the neurovascular diseases segment is anticipated to record the fastest CAGR of 9.04% during the forecast period (2024-2032), due to the increasing number of ischemic strokes and technological advancements, which have resulted in more uptake of carotid and intracranial interventions.
By Indication, Percutaneous Coronary Intervention Lead, Whereas Transcatheter Aortic Valve Replacement Registers the Fastest Growth
Percutaneous coronary intervention segment led the embolic protection devices market with the highest revenue market share of about 40.88% in 2024, owing to the PCI procedures have been the largest application of EPDs, in particular for high-risk coronary lesions. Key contributing elements are the established effect of reducing distal embolization, strong clinical data. The transcatheter aortic valve segment is likely to register the fastest CAGR of approximately 9.54% over the forecast years 2024-2032, driven by the rise of TAVR procedures and the growth in awareness of stroke prevention. Rising incidence of ischemic strokes, aggressive clinical trials supporting brain protection.
By End-User, Hospitals Lead, While Ambulatory Care Centers Grow the Fastest
The hospital segment of the embolic protection devices market was estimated as the highest earning segment with a revenue share of around 72.88% in 2024. Highly specialized cath labs, expert interventional cardiologists, robust clinical back-up, high procedure volumes, and favorable reimbursement coverage drive the pulse oximetry market. The ambulatory care centers segment is projected to attain the highest CAGR of approximately 9.00% throughout the forecast period (2024-2032), driven by the trend of elective PCI, carotid, and peripheral interventions in the outpatient environment. Factors driving the growth in EPD utilization in ASCs include cost savings, a shorter recovery time for patients, and policies over payors reimbursing for devices.
Asia Pacific Gaming Accessories Market Insights
The Asia Pacific segment is projected to witness the fastest CAGR of 9.43% during the forecast period of 2024–2032, owing to a rise in stroke prevention awareness, higher uptake of procedures including PCI and TAVR, growing investments by major healthcare players, and proactive government measures will enhance market penetration and high growth opportunities across emerging nations in the region.
North America Gaming Accessories Market Insights
North America accounted for the highest revenue share of approximately 29.76% in 2024 of the embolic protection devices market, owing to the high prevalence of CVD, developed healthcare infrastructure, and high usage of PCI, TAVR, and carotid interventions. Key drivers include the compelling clinical evidence of stroke and embolic complication prevention, positive reimbursement policies, high physician awareness, and uptake of technology
Europe Embolic Protection Devices Market Insights
The Europe embolic protection devices market is growing steadily owing to the rising burden of cardiovascular and carotid artery diseases, mature healthcare infrastructural development, and surging demand for PCI, TAVR, and carotid stenting procedures. Robust clinical evidence, encouraging reimbursement policies, and growing physician interest further propel the market.
Latin America (LATAM) and Middle East & Africa (MEA) Embolic Protection Devices Market Insights
The Middle East & Africa and Latin America markets are also increasing owing to poor health care resources, inadequate knowledge of embolic protection, and limited exposure to sophisticated interventions. Device cost, lack of reimbursement, and a lack of trained interventional cardiologists also hold adoption back to some extent, leading to a significantly smaller market presence than in North America, Europe, or the Asia Pacific.
Embolic Protection Devices Market Growth Drivers:
-
Evidence-based Clinical Outcomes are Driving the Embolic Protection Devices Market Growth
Clinical trials reporting major decreases in stroke and embolic events during cardiovascular procedures will be one of the major factors driving the embolic protection devices market growth. These evidence-based results enhance physician confidence, promote hospital adoption, and aid payer reimbursement. Consequently, the greater number of procedures, including PCI, TAVR, and carotid stenting, being undertaken with EPDs is driving market penetration and adoption in all markets.
For instance, in June 2024, a European Stroke Organization study reported that embolic protection devices reduced periprocedural stroke rates by 38% during carotid stenting, boosting EPD market adoption.
Embolic Protection Devices Market Restraints:
-
Procedure Complexity and Learning Curve are Hampering the Embolic Protection Devices Market Growth
The technical complexity of the procedure, combined with the relatively steep learning curve for the use of embolic protection devices, may contribute to a slow rate of adoption, as the medical professional needs to be well-trained in order to use them safely and effectively. This restraint is applicable to the embolic protection devices market growth, especially in some mid-size hospitals and ambulatory care centers. Breaking this barrier with education programs and simplified device designs is essential to increasing global acceptance and market penetration.
Embolic Protection Devices Market Opportunities:
-
Emerging Markets Penetration, Significant Growth Opportunities in Embolic Protection Devices Market
The incidence of cardiovascular diseases is accelerating in Asia-Pacific, Latin America, and the Middle East, resulting from population aging, urbanisation, and lifestyle transformation. These parts of the globe have poor availability of sophisticated cardiovascular devices, so embolic protection device makers can capitalize on these opportunities. Growing investments in healthcare, better infrastructure, and increasing medical tourists will act as a catalyst for the adoption of innovative treatment modalities in a virgin healthcare market.
For instance, in July 2025, Cardiovascular diseases cause 60% of deaths in low- and middle-income nations; China and India report 30M+ new cases annually, boosting EPD demand.
Competitive Landscape for Embolic Protection Devices Market:
Abbott Laboratories was established in 1888 and is headquartered in Illinois, USA. It is a leading global health care company that is involved in a range of between nutrition, diagnostics, medical devices, and branded generic pharmaceuticals. The company is known for breakthroughs in cardiovascular care, diabetes management, and diagnostic testing. Operating in more than 160 countries, Abbott’s focus is to provide innovative solutions that health professionals and patients trust, along with the support they need, through technological and scientific advancements.
-
In July 2024, Abbott reported real-world data showing FilterWire EZ reduces distal embolization by 35% during high-risk PCI, supporting physician adoption and boosting EPD market growth.
Edwards Lifesciences Corporation, incorporated on September 10, 1999, is focused on technologies that treat structural heart disease and critically ill patients. The company is most widely known for its pioneering transcatheter heart valve therapies and the SAPIEN valve portfolio. Edwards, which serves many of the world's most clinically challenging patients, including nearly 1 million surgical and transcatheter heart valve patients globally, focuses on partnering with clinicians to develop innovative, patient-focused products and services.
-
In May 2025, Edwards expanded TriGuard cerebral protection device availability in Europe and Asia, enhancing TAVR stroke prevention and accelerating global EPD adoption.
Terumo Corporation Established in 1921 and headquartered in Tokyo, Japan, Terumo is one of the world's leading medical device manufacturers, with USD 5.3 billion of sales and operations in more than 160 nations. The company is known for its next-generation interventional cardiology products, including catheters, stents, and embolic protection devices. Terumo, which works in over 160 countries, is dedicated to innovation, quality, and patient safety.
-
In April 2025, Terumo introduced the FineCross MG micro-guide catheter in Japan and Europe, offering enhanced flexibility and support to improve access and outcomes in challenging complex coronary interventions.
Embolic Protection Devices Market Key Players:
Some of the Embolic Protection Devices Market Companies
-
Boston Scientific Corporation
-
Medtronic plc
-
Abbott Laboratories
-
Edwards Lifesciences Corporation
-
Cordis
-
Silk Road Medical, Inc.
-
Terumo Corporation
-
Merit Medical Systems, Inc.
-
Claret Medical, Inc.
-
MicroPort Scientific Corporation
-
Contego Medical, Inc.
-
Keystone Heart Ltd.
-
Protembis GmbH
-
InspireMD, Inc.
-
Lepu Medical Technology
-
Allium Medical Solutions Ltd.
-
AngioDynamics, Inc.
-
Cardinal Health, Inc.
-
Shockwave Medical, Inc.
-
Cardiawave SA
Embolic Protection Devices Market Report Scope
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 656.60 million |
| Market Size by 2032 | USD 1276.14 million |
| CAGR | CAGR of 8.68% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Proximal Occlusion Systems, Distal Occlusion Systems, Distal Filters) • By Application (Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases) • By Indication (Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications) • By End User (Hospitals, Ambulatory Care Centers) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Poland, Russsia, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia,ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia Rest of Latin America) |
| Company Profiles | Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Cordis, Silk Road Medical, Inc., Terumo Corporation, Merit Medical Systems, Inc., Claret Medical, Inc., MicroPort Scientific Corporation, Contego Medical, Inc., Keystone Heart Ltd., Protembis GmbH, InspireMD, Inc., Lepu Medical Technology, Allium Medical Solutions Ltd., AngioDynamics, Inc., Cardinal Health, Inc., Shockwave Medical, Inc., Cardiawave SA and other players. |
Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Application
2.3.2 Market Size By Indication
2.3.2 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Procedure Volume & Clinical Application Trends (2020–2032)
4.1.1 Global and regional procedure volumes using embolic protection devices
4.1.2 Growth rate comparison: interventional cardiology vs peripheral vascular vs neurovascular applications
4.1.3 Elective vs emergency cardiovascular procedure trends involving EPDs
4.2 Patient Demographics & Utilization (2024)
4.2.1 Age-wise and gender-wise patient distribution in EPD-supported interventions
4.2.2 Urban vs rural utilization patterns in high-prevalence cardiovascular regions
4.2.3 Insurance coverage and reimbursement access for EPD-related procedures
4.3 Technology & Product Development Trends (2020–2025)
4.3.1 Distribution of EPDs by type: distal filters, proximal occlusion, combined systems
4.3.2 Number of new EPD product launches and regulatory approvals annually
4.3.3 Advancements in device design: miniaturization, deliverability, and material innovations
4.4 Market Access & Reimbursement Landscape (2024)
4.4.1 Share of EPD procedures reimbursed by Medicare, Medicaid, private payers, and out-of-pocket
4.4.2 Reimbursement rate comparison: EPDs vs non-EPD interventional procedures
4.4.3 Adoption of bundled payments, value-based care, and cost-effectiveness studies
4.5 Cost Efficiency & Clinical Outcome Benefits (2024)
4.5.1 Average cost savings from stroke and embolic complication prevention using EPDs
4.5.2 Price comparison of major EPDs across regions and manufacturers
4.5.3 Trends in outcome-based evidence driving physician and patient preference
5. Embolic Protection Devices Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Proximal Occlusion Systems
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Distal Occlusion Systems
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Distal Filters
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. Embolic Protection Devices Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Cardiovascular Diseases
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Neurovascular Diseases
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Peripheral Diseases
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Embolic Protection Devices Market Segmental Analysis & Forecast, By Indication, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Percutaneous Coronary Intervention
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Carotid Artery Diseases Saphenous Vein Graft Disease
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Transcatheter Aortic Valve Replacement
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Other Indications
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
8. Embolic Protection Devices Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Ambulatory Care Centers
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
9. Embolic Protection Devices Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.4 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.2.5 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Embolic Protection Devices Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.6.1.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.2.6.1.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.6.2.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.2.6.2.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.4 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.5 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Embolic Protection Devices Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.1.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.1.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.2.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.2.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.3.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.3.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.4.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.4.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.5.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.5.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.6.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.6.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.7.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.7.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.8.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.8.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.4 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.5 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Embolic Protection Devices Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.1.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.1.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.2.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.2.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.3.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.3.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.4.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.4.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.5.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.5.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.6.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.6.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.7.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.7.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.4 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.5 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Embolic Protection Devices Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.1.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.1.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.2.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.2.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.3.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.3.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.4.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.4.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.5.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.5.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.4 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.5 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Embolic Protection Devices Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.1.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.1.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.2.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.2.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.3.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.3.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.4.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.4.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.5.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.5.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Embolic Protection Devices Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Embolic Protection Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.6.3 Embolic Protection Devices Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.6.4 Embolic Protection Devices Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Boston Scientific Corporation
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Medtronic plc
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Abbott Laboratories
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Edwards Lifesciences Corporation
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Cordis
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Silk Road Medical, Inc.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Terumo Corporation
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Merit Medical Systems, Inc.
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Claret Medical, Inc.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 MicroPort Scientific Corporation
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Contego Medical, Inc.
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Keystone Heart Ltd.
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Protembis GmbH
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 InspireMD, Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Lepu Medical Technology
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Allium Medical Solutions Ltd.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 AngioDynamics, Inc.
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Cardinal Health, Inc.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Shockwave Medical, Inc.
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Cardiawave SA
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments:
By Product
-
Proximal Occlusion Systems
-
Distal Occlusion Systems
-
Distal Filters
By Application
-
Cardiovascular Diseases
-
Neurovascular Diseases
-
Peripheral Diseases
By Indication
-
Percutaneous Coronary Intervention
-
Carotid Artery Diseases Saphenous Vein Graft Disease
-
Transcatheter Aortic Valve Replacement
-
Other Indications
By End User
-
Hospitals
-
Ambulatory Care Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
ASEAN Countries
-
Australia
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
